Results
1 -
10 of
96
(Click
here to explore results)
Drug Discovery for Psychiatric Disorders, CHAPTER 3 Monoaminergic Approaches for Treatment of Schizophrenia . David P. Rotella
, 2012
, Pages 35-55
Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 13 5‐HT1A Receptors as a Therapeutic Target for Parkinson’s Disease . Saki Shimizu, Yukihiro Ohno
, 2013
, Pages 308-326
Electrochemical Detection in HPLC: Analysis of Drugs and Poisons, Applications of HPLC-ED in the analysis of drugs . Roger M. Smith, Robert J. Flanagan, David Perrett, Robin Whelpton
, 2005
, Pages 104-210
Supramolecular Systems in Biomedical Fields, CHAPTER 11 Supramolecular Gels for Pharmaceutical and Biomedical Applications . Juan F. Miravet, Beatriu Escuder
, 2013
, Pages 331-354
Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 10 Glutamate Receptor Modulators as Emergent Therapeutic Agents in the Treatment of Parkinson’s Disease . Sylvain Célanire, Benjamin Perry, Robert Lutjens, Sonia Poli, Ian J. Reynolds
, 2013
, Pages 237-265
Foreign Compound Metabolism in Mammals: Volume 5, Effect of drugs on the central nervous system . D. E. Hathway, B. E. Leonard
, 1979
, Volume 5
, Pages 244-319
Drug Design Strategies: Computational Techniques and Applications, Chapter 6 Quantum Chemical Topology: on Descriptors, Potentials and Fragments . Paul L. A. Popelier
, 2012
, Pages 120-163
Designing Multi-Target Drugs, Chapter 16 Discovery of the Anti-Psychotic Drug, Ziprasidone . John A. Lowe, III
, 2012
, Pages 263-269
Drug Discovery for Schizophrenia, CHAPTER 8 GSK3 Networks in Schizophrenia . Jivan Khlghatyan, Gohar Fakhfouri, Jean-Martin Beaulieu
, 2015
, Pages 173-201
Drug Discovery for Psychiatric Disorders, CHAPTER 19 Multi-target Drug Discovery for Psychiatric Disorders . Zoran Rankovic, Richard Morphy
, 2012
, Pages 510-533